Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
Sponsor: JW Pharmaceutical
Summary
This clinical study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation clinical trial to evaluate the safety, pharmacokinetic and pharmacodynamics of JW0061 following topical application in Korean and Caucasians healthy adults.
Official title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose Escalation Clinical Trial to Evaluate the Safety, Pharmacokinetic and Pharmadynamics of JW0061 Following Topical Application in Korean and Caucasians Healthy Adults
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
104
Start Date
2026-03-31
Completion Date
2027-04-30
Last Updated
2026-04-07
Healthy Volunteers
Yes
Conditions
Interventions
JW0061 SAD
Single ascending doses
JW0061 MAD
Multiple ascending doses
Placebo
Matching placebo for JW0061
Locations (1)
Seoul National University Hospital Clinical Trial Center
Seoul, Seoul, South Korea